|
🐜
|
X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.
25 auth.
J. Jais,
B. Knebelmann,
I. Giatras,
M. Marchi,
G. Rizzoni,
A. Renieri,
Manfred Weber,
O. Gross,
K. Netzer,
F. Flinter,
Y. Pirson,
C. Verellen,
J. Wieslander,
U. Persson,
K. Tryggvason,
...
Paula Martin,
J. Hertz,
Cornelis SCHR̈ODER,
M. Sanak,
Š. Krejčová,
M. Carvalho,
J. Saus,
C. Antignac,
H. Smeets,
M. Gubler
|
8 |
2000 |
8
🐜
|
|
🐜
|
X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.
24 auth.
J. Jais,
B. Knebelmann,
I. Giatras,
M. de Marchi,
G. Rizzoni,
A. Renieri,
Manfred Weber,
O. Gross,
K. Netzer,
F. Flinter,
...
Y. Pirson,
K. Dahan,
J. Wieslander,
U. Persson,
K. Tryggvason,
Paula Martin,
J. Hertz,
C. Schröder,
M. Sanak,
M. Carvalho,
J. Saus,
C. Antignac,
H. Smeets,
M. Gubler
|
8 |
2003 |
8
🐜
|
|
🐜
|
Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper
21 auth.
M. Kowalski,
I. Agache,
S. Bavbek,
A. Bakırtaş,
M. Blanca,
G. Bochenek,
M. Bonini,
E. Heffler,
L. Klimek,
T. Laidlaw,
...
J. Mullol,
E. Nizankowska-Mogilnicka,
Hae‐Sim Park,
M. Sanak,
M. Sánchez-Borges,
S. Sánchez-García,
G. Scadding,
M. Taniguchi,
M. Torres,
Andrew A. White,
A. Wardzyńska
|
8 |
2018 |
8
🐜
|
|
🐜
|
U‐BIOPRED clinical adult asthma clusters linked to a subset of sputum omics
30 auth.
D. Lefaudeux,
B. de Meulder,
M. Loza,
N. Peffer,
A. Rowe,
F. Baribaud,
A. Bansal,
R. Lutter,
A. Sousa,
J. Corfield,
I. Pandis,
P. Bakke,
M. Caruso,
P. Chanez,
S. Dahlén,
...
L. Fleming,
S. Fowler,
I. Horváth,
N. Krug,
P. Montuschi,
M. Sanak,
T. Sandstrom,
D. Shaw,
F. Singer,
P. Sterk,
G. Roberts,
I. Adcock,
R. Djukanović,
C. Auffray,
K. Chung
|
7 |
2017 |
7
🐜
|
|
🦁
|
Leukotriene C
4
synthase promoter polymorphism and risk of aspirin-induced asthma
M. Sanak,
H. Simon,
A. Szczeklik
|
7 |
1997 |
7
🦁
|
|
🐢
|
Stop codon FGFR3 mutations in thanatophoric dwarfism type 1
9 auth.
F. Rousseau,
P. Saugier,
M. Merrer,
A. Munnich,
A. Delezoide,
P. Maroteaux,
...
J. Bonaventure,
F. Narcy,
M. Sanak
|
7 |
1995 |
7
🐢
|
|
🐬
|
Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma.
L. Mastalerz,
M. Setkowicz,
M. Sanak,
A. Szczeklik
|
7 |
2004 |
7
🐬
|
|
🐜
|
Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients
13 auth.
P. Wawrzyniak,
M. Wawrzyniak,
Kerstin Wanke,
M. Sokolowska,
K. Bendelja,
B. Rückert,
Anna Głobińska,
B. Jakieła,
Jeannette I. Kast,
M. Idzko,
...
M. Akdiş,
M. Sanak,
C. Akdis
|
7 |
2017 |
7
🐜
|
|
🦁
|
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics.
8 auth.
M. Sanak,
B. Levy,
C. Clish,
Chia Nan,
K. Gronert,
L. Mastalerz,
...
C. Serhan,
A. Szczeklik
|
7 |
2000 |
7
🦁
|
|
🐬
|
Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma.
W. Szczeklik,
M. Sanak,
A. Szczeklik
|
7 |
2004 |
7
🐬
|
|
🐜
|
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
23 auth.
N. McElvaney,
J. Burdon,
M. Holmes,
A. Glanville,
P. Wark,
Philip J. Thompson,
P. Hernandez,
J. Chlumsky,
H. Teschler,
J. Ficker,
...
N. Seersholm,
A. Altraja,
R. Mäkitaro,
J. Chorostowska-Wynimko,
M. Sanak,
P. Stoicescu,
E. Piitulainen,
O. Vit,
M. Wencker,
M. Tortorici,
Michael Fries,
J. Edelman,
K. Chapman
|
7 |
2017 |
7
🐜
|
